Senna
- Product NDC
- 0904-6289
- 11-digit product format
- 009046289
- Labeler code
- 0904
- Product ID
- 0904-6289_08eee169-2274-445d-b34e-99258fcc3507
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Sennosides A and B
- Dosage form
- SYRUP
- Route
- ORAL
- Labeler
- Major Pharmaceuticals
- Application
- part334
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2012-04-23
- Marketing end
- 2019-10-13
- Substance
- SENNOSIDES A AND B
- Active strength
- 9 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0904-6289-09 | ML - Milliliter | 0904-6289 | 243da47c-1a51-4373-8b52-93808b142f01 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Sennosides A and B | ACTIVE INGREDIENT | 1B5FPI42EN | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| Sennosides A and B | ACTIVE MOIETY | 1B5FPI42EN | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| COCOA | INACTIVE INGREDIENT | D9108TZ9KG | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | SENNA (SENNOSIDES A AND B) SYRUP [CARILION MATERIALS MANAGEMENT] | 2 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | 34c3346d-2db4-4410-be4e-9b1c197f2f37 | 4 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | 34c3346d-2db4-4410-be4e-9b1c197f2f37 | 4 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | 34c3346d-2db4-4410-be4e-9b1c197f2f37 | 4 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | 34c3346d-2db4-4410-be4e-9b1c197f2f37 | 4 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | 34c3346d-2db4-4410-be4e-9b1c197f2f37 | 4 |
| 702311 | sennosides 8.8 MG in 5 mL Oral Solution | PSN | e221e66f-edb9-4c8a-8c75-5eca4ae8aa6d | 2 |
| 702311 | sennosides, USP 1.76 MG/ML Oral Solution | SCD | e221e66f-edb9-4c8a-8c75-5eca4ae8aa6d | 2 |
| 702311 | sennosides 8.8 MG per 5 mL Oral Syrup | SY | e221e66f-edb9-4c8a-8c75-5eca4ae8aa6d | 2 |
| 702311 | sennosides, USP 26.4 MG per 15 ML Oral Solution | SY | e221e66f-edb9-4c8a-8c75-5eca4ae8aa6d | 2 |
| 702311 | sennosides, USP 8.8 MG per 5 ML Oral Solution | SY | e221e66f-edb9-4c8a-8c75-5eca4ae8aa6d | 2 |